Corvus Pharmaceuticals (CRVS) Stock Price
$3.24 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Corvus Pharmaceuticals, AI stock picks, stock alerts and much more.
CRVS AI Stock Analysis
AI stock analysis for CRVS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Corvus Pharmaceuticals (CRVS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Corvus Pharmaceuticals (CRVS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Corvus Pharmaceuticals (CRVS), currently trading at $3.24, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CRVS
-
Corvus Pharmaceuticals, Inc.
-
Symbol
CRVS
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
220.8M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
CRVS Alternative Data
Web Traffic
Corvus Pharmaceuticals receives an estimated 4432 monthly visitors to corvuspharma.com.
-
Web Traffic
4432
-
Change from Previous Month
29%
-
3 Month Change
24.4%
-
YoY Change
24.4%
News Mentions
Corvus Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Corvus Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Followers
6,830 are following Corvus Pharmaceuticals on LinkedIn, up by 0.7% over the last month.
-
LinkedIn Followers
6830
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
2.2%
Job Postings
Corvus Pharmaceuticals has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Employees
According to LinkedIn, Corvus Pharmaceuticals has 41 employees.
-
LinkedIn Employees
41
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
5.1%
-
YoY Change
5.1%
Business Outlook
According to employee reviews, the business outlook among employees at Corvus Pharmaceuticals is 58 out of 100 (neutral).
-
Business Outlook
58
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
CRVS Financials
CRVS Key Metrics
-
Total Revenue
$0
-
Net Income
-$12.1M
-
Earnings per Share
-$0.2
-
Free cash flow
-$8.5M
-
EBITDA
-$8.1M
-
EBITDA Ratio
0
-
Total Assets
$68.9M
CRVS 2-year Revenue & Income
CRVS 2-year Free Cash Flow
CRVS Technicals
CRVS SMA
CRVS RSI
FAQ
What's the current price of Corvus Pharmaceuticals (CRVS) Stock?
The price of an Corvus Pharmaceuticals (CRVS) share is $3.24.
What's the market cap of Corvus Pharmaceuticals?
The current market cap of Corvus Pharmaceuticals is 220.8M.
Should I buy or sell CRVS?
Corvus Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Corvus Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Corvus Pharmaceuticals a good investment?
The current analysis of Corvus Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Corvus Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Corvus Pharmaceuticals (CRVS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Corvus Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Corvus Pharmaceuticals (CRVS) that investors often compare it to?
Corvus Pharmaceuticals (CRVS) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Corvus Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Corvus Pharmaceuticals' stock price to be around $3.06 in 2026. Starting from the current price of $3.24, this represents a 5.5% change in price, indicating a bearish outlook for the stock.
How to buy Corvus Pharmaceuticals (CRVS) Stock?
Corvus Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Corvus Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.